Thrombolex, Inc.

Join Dr. Patrick Muck during VEINS 2024 today at 10:05am for an in-depth review of single-session outcomes using the BASHIR™ Endovascular Catheter for the treatment of Pulmonary Embolism (PE). #VEINS #Thrombolex Thrombolex.com

Join us at VEINS 2024 in Las Vegas to learn more about our innovative solutions for treating thromboembolic diseases with clinically proven safety and efficacy. #VEINS #Thrombolex Thrombolex.com

Another insightful conference at TCT 2024. Thank you to everyone who visited our booth and engaged with our team. A special thanks to Dr. Riyaz Bashir, Dr. Christian Bichard, and Dr. Wissam Jaber, as well as the attendees of the Innovations in Endovascular Therapies session that reviewed the compelling results of our RESCUE-II Trial. Thrombolex looks forward to shaping the future of PE treatment and enhancing patient outcomes with the BASHIR™ Endovascular Catheter. #Thrombolex Thrombolex.com

Happy Halloween from all of us at Thrombolex. Thrombolex.com #Thrombolex #HappyHalloween

The BASHIR™ Plus Endovascular Catheter is a groundbreaking advancement in the treatment of arterial and deep vein thrombosis. Its dual mode of action features a unique expandable infusion basket that allows for optimal thrombosis fragmentation and resolution. Thrombolex.com #Thrombolex

Compelling results of the RESCUE II Clinical Trial were recently presented during TCT 2024. Dr. Christian Bichard shared data from patients with acute intermediate-risk pulmonary embolism (PE) treated with the BASHIR™ Endovascular Catheter. Conducted at Temple University by Drs. Riyaz Bashir and Vladimir Lakhter, the study highlights the effectiveness of single-session pharmacomechanical lysis (PML) without the need for post-procedural thrombolytic infusion. #Thrombolex https://lnkd.in/eNUhhr37

Join Dr. Christian Bichardin the Innovation Theater tomorrow (10/28) morning at 9:34am for an in-depth review of the compelling results of the RESCUE II Study in treating acute intermediate-risk Pulmonary Embolism (PE). The RESCUE II Study, conducted at Temple University by Drs. Riyaz Bashir and Vladimir Lakhter, demonstrates the remarkable efficacy of the BASHIR™ Endovascular Catheter in providing rapid, on-table pharmacomechanical lysis (PML) without the need for prolonged post-procedural thrombolytic infusion. Thrombolex.com #Thrombolex

The BASHIR™ Plus Family of Endovascular Catheters enables the restoration of blood flow for peripheral vessels with extensive thrombus burden. The mechanical expansion and optimized delivery of r-tPA through the basket and along the length of the catheter offer an individualized approach to treating peripheral venous disease. Thrombolex.com #Thrombolex

Join Thrombolex at Booth 813 at TCT 2024 to explore how our innovative endovascular catheters can revolutionize pulmonary embolism treatment in a single session. Thrombolex.com #Thrombolex

Visit Thrombolex at Booth 813 during the TCT Conference in Washington, D.C. and be sure to attend the Innovations in Endovascular Therapies Session on 10/28 where Dr. Christian Bichard will present the compelling results from the RESCUE II Study. Thrombolex.com #Thrombolex